Immune Marker Identified as Predictor of Poor Outcomes Across Multiple Tumor Types and Species
In a groundbreaking study poised to reshape our understanding of cancer progression, researchers at Ludwig Lausanne have unveiled a pivotal gene expression program within tumor-associated...
















